About: Current regulatory approaches for accessing potential COVID-19 therapies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Current regulatory approaches for accessing potential COVID-19 therapies Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Current regulatory approaches for accessing potential COVID-19 therapies
Creator	Daci, Armond Filipce, Venko Grozdanova, Aleksandra Halimi, Vesa Panovska-Stavridis, Irina Stevanovic, Milena Stojanovska, Simona
source	Medline; PMC
abstract	This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.
has issue date	2020-05-16(xsd:dateTime)
bibo:doi	10.1186/s40545-020-00222-6
bibo:pmid	32454981
has license	cc-by
sha1sum (hex)	d7080c93cbea57445c4845ae12ed6e4502fe1ef5
schema:url	https://doi.org/10.1186/s40545-020-00222-6
resource representing a document's title	Current regulatory approaches for accessing potential COVID-19 therapies
has PubMed Central identifier	PMC7229878
has PubMed identifier	32454981
schema:publication	J Pharm Policy Pract
resource representing a document's body	covid:d7080c93cbea57445c4845ae12ed6e4502fe1ef5#body_text
is schema:about of	named entity 'communication' named entity 'RESEARCHERS' named entity 'COMMENTARY' named entity 'FAIR' named entity 'COVID-19' named entity 'fair' named entity 'therapies' named entity 'emergency' named entity 'clinicians' named entity 'authorities' named entity 'regulatory authorities' named entity 'clinical trials' named entity 'FDA' named entity 'retinitis' named entity 'study designs' named entity 'regulatory authorities' named entity 'colitis' named entity 'CMV' named entity 'monoclonal antibodies' named entity 'regulatory authorities' named entity 'emergency conditions' named entity 'COVID-19' named entity 'COVID-19' named entity 'study design' named entity 'CMV' named entity 'COVID-19' named entity 'blood products' named entity 'informed consent' named entity 'CMV' named entity 'pneumonia' named entity 'COVID-19' named entity 'Cytomegalovirus' named entity 'clinical studies' named entity 'COVID-19' named entity 'clinical studies' named entity 'interferon beta' named entity 'medical supply' named entity 'EMA' named entity 'regulatory authorities' named entity 'sample size' named entity 'COVID-19' named entity 'COVID-19' named entity 'EMA' named entity 'informed consent' named entity 'control group' named entity 'clinical studies' named entity 'scientific evidence' named entity 'fluid management' named entity 'clinical studies' named entity 'clinical studies' named entity 'Grein' named entity 'clinically meaningful' named entity 'lopinavir/ritonavir' named entity 'regulatory requirements' named entity 'regulatory authorities' named entity 'COVID-19' named entity 'follow-up' named entity 'COVID-19' named entity 'MERS -CoV' named entity 'EMA' named entity 'COVID-19' named entity 'Ganciclovir' named entity 'methodological issues' named entity 'Remdesivir' named entity 'clinical practice' named entity 'clinical trials' named entity 'study design' named entity 'European Medicines Agency' named entity 'clinical trials' named entity 'antibody' named entity 'SARS' named entity 'convalescent plasma' named entity 'hydroxychloroquine' named entity 'compassionate use programs' named entity 'off-label'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software